ELCC 2024 | Six Innovations on Aumolertinib, Originally Developed by Hansoh Pharma, Selected for International Academic Assembly
The European Lung Cancer Congress (ELCC 2024) will be held in Prague, the capital of the Czech Republic, from March 20 to 23, 2024, and six innovative...
2024.03.21